Phase II trial of idarubicin in patients with pancreatic cancer

Cancer Treat Rep. 1987 Jun;71(6):657-8.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Daunorubicin / adverse effects
  • Daunorubicin / analogs & derivatives*
  • Daunorubicin / therapeutic use
  • Drug Evaluation
  • Female
  • Humans
  • Idarubicin
  • Male
  • Middle Aged
  • Pancreatic Neoplasms / drug therapy*
  • Pancreatic Neoplasms / pathology

Substances

  • Idarubicin
  • Daunorubicin